Pre-emptive therapy with cidofovir in adenovirus infection after stem cell transplantation (SCT) in children

被引：0
|
作者：
de Heredia, CD [1 ]
Olivé, T [1 ]
Calicó, I [1 ]
Orlega, JJ [1 ]
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [41] PRE-EMPTIVE TREATMENT OF CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS WHO UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Atay, D.
    Ozturk, G.
    Anak, S.
    Akcay, A.
    Tugcu, D.
    Garipardic, M.
    Devecioglu, O.
    Karakas, Z.
    Unuvar, A.
    Agaoglu, L.
    HAEMATOLOGICA, 2013, 98 : 661 - 661
  • [42] Ribavirin prophylaxis and pre-emptive cidofovir treatment protect paediatric stem cell transplant recipients from life-threatening adenovirus infections
    Greil, J
    Klein, A
    Bader, P
    Ebinger, M
    Beck, R
    Bock, TC
    Feuchtinger, T
    Blumenstock, G
    Niethammer, D
    Handgretinger, R
    Lang, P
    BONE MARROW TRANSPLANTATION, 2006, 37 : S166 - S166
  • [43] Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections
    Chakrabarti, S
    Collingham, KE
    Osman, H
    Fegan, CD
    Milligan, DW
    BONE MARROW TRANSPLANTATION, 2001, 28 (09) : 879 - 881
  • [44] Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections
    S Chakrabarti
    KE Collingham
    H Osman
    CD Fegan
    DW Milligan
    Bone Marrow Transplantation, 2001, 28 : 879 - 881
  • [45] Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
    Andersen, Niels S.
    Pedersen, Lone B.
    Laurell, Anna
    Elonen, Erkki
    Kolstad, Arne
    Boesen, Anne Marie
    Pedersen, Lars M.
    Lauritzsen, Grete F.
    Ekanger, Roald
    Nilsson-Ehle, Herman
    Nordstrom, Marie
    Freden, Susanne
    Jerkeman, Mats
    Eriksson, Mikael
    Vaart, Jaan
    Malmer, Beatrice
    Geisler, Christian H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4365 - 4370
  • [46] Valganciclovir for pre-emptive therapy of cytomegalovirus viraemia after hematopoietic stem cell transplantation: a prospective multi-center trial
    Liu Kai-yan
    Wang Yu
    Han Ming-zhe
    Huang He
    Chen Hu
    Liu Qi-fa
    Wang Jian-min
    Liu Ting
    Song Yong-ping
    Ma Jun
    Wu De-pei
    Zou Ping
    Huang Xiao-jun
    CHINESE MEDICAL JOURNAL, 2010, 123 (16) : 2199 - 2205
  • [47] Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
    Green, Margaret L.
    Leisenring, Wendy
    Xie, Hu
    Mast, T. Christopher
    Cui, Yadong
    Sandmaier, Brenda M.
    Sorror, Mohamed L.
    Goyal, Sonia
    Oezkoek, Sezen
    Yi, Jessica
    Sahoo, Farah
    Kimball, Louise E.
    Jerome, Keith R.
    Marks, Morgan A.
    Boeckh, Michael
    LANCET HAEMATOLOGY, 2016, 3 (03): : E119 - E127
  • [48] Valganciclovir for pre-emptive therapy of cytomegalovirus viraemia after hematopoietic stem cell transplantation:a prospective multi-center trial
    LIU Kai-yan
    中华医学杂志（英文版）, 2010, (16) : 2199 - 2205
  • [49] Cidofovir in children after allogeneic stem cell transplantation
    Fernández-Sanmartin, M
    Izquierdo, M
    Fernández-Navarro, JM
    Verdeguer, A
    Castel, V
    BONE MARROW TRANSPLANTATION, 2004, 33 : S231 - S232
  • [50] Valganciclovir is safe and effective as pre-emptive treatment for CMV infection in allogeneic hematopoietic stem cell transplantation.
    Pastano, Rocco
    Gigli, Federica
    Andreola, Giovanna
    Calabrese, Liliana
    Peccatori, Fedro
    Martinelli, Giovanni
    BLOOD, 2006, 108 (11) : 417B - 417B
12345